Data as of Q4 2025 (Dec 31, 2025)
LYEL

LYELL IMMUNOPHARMA INC

Institutional Ownership · Q4 2025

Filing: Q4 2025

LYELL IMMUNOPHARMA INC (LYEL) is held by 66 institutional investors with combined holdings of $355M. Major holders include ARCH Venture Management, , GSK plc (GSK, GLAXF), MWG Caph Ltd.

💰 Dark Pool Activity👤 Insider Trades
Institutional Holders
66
Total Value
$355.1M
Ownership %
49.5%

🏦 Top Institutional Holders

ARCH Venture Management, LLC
2.8M shares
$84.9M
11.83% ownership
GSK plc (GSK, GLAXF)
1.5M shares
$46.6M
6.48% ownership
MWG Caph Ltd
1.0M shares
$31.0M
4.32% ownership
VANGUARD GROUP INC
826.4K shares
$25.4M
3.54% ownership
Foresite Capital Management IV, LLC
800.4K shares
$24.6M
3.43% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.